PT  - JOURNAL ARTICLE
AU  - Tan, Le Van
AU  - Hong, Nguyen Thi Thu
AU  - Ngoc, Nghiem My
AU  - Thanh, Tran Tan
AU  - Lam, Vo Thanh
AU  - Nguyet, Lam Anh
AU  - Nhu, Le Nguyen Truc
AU  - Ny, Nguyen Thi Han
AU  - Minh, Ngo Ngoc Quang
AU  - Man, Dinh Nguyen Huy
AU  - Hang, Vu Thi Ty
AU  - Khanh, Phan Nguyen Quoc
AU  - Xuan, Tran Chanh
AU  - Phong, Nguyen Thanh
AU  - Tu, Tran Nguyen Hoang
AU  - Hien, Tran Tinh
AU  - Hung, Le Manh
AU  - Truong, Nguyen Thanh
AU  - Yen, Lam Minh
AU  - Dung, Nguyen Thanh
AU  - Thwaites, Guy
AU  - Chau, Nguyen Van Vinh
AU - for OUCRU COVID-19 research group
TI  - SARS-CoV-2 detection in nasopharyngeal throat swabs by metagenomics
AID  - 10.1101/2020.05.24.20110205
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.24.20110205
4099  - http://medrxiv.org/content/early/2020/05/26/2020.05.24.20110205.short
4100  - http://medrxiv.org/content/early/2020/05/26/2020.05.24.20110205.full
AB  - Metagenomics could detect SARS-CoV-2 in all eight nasopharyngeal/throat swabs with high/low viral loads, and rhinovirus in a co-infected patient. The sequenced viruses belonged to lineage B1. Because metagenomics could detect novel pathogen and co-infection, and generate sequence data for epidemiological investigation, it is an attractive approach for infectious-disease diagnosis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Wellcome Trust of Great Britain (106680/B/14/Z and 204904/Z/16/Z).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Review Board of the HTD and the Oxford Tropical Research Ethics Committee of the University of OxfordAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesProvided with in the ms is the essential information. Additional information will be available upon reasonable request.